FORNAI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 46.005
EU - Europa 21.498
AS - Asia 20.937
SA - Sud America 3.608
AF - Africa 614
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 20
Totale 92.793
Nazione #
US - Stati Uniti d'America 40.053
IT - Italia 8.394
SG - Singapore 6.466
CN - Cina 6.179
CA - Canada 5.602
HK - Hong Kong 4.019
BR - Brasile 2.889
PL - Polonia 2.465
DE - Germania 1.877
SE - Svezia 1.822
BG - Bulgaria 1.588
VN - Vietnam 1.180
GB - Regno Unito 1.101
UA - Ucraina 967
TR - Turchia 867
RU - Federazione Russa 758
KR - Corea 724
FI - Finlandia 711
AT - Austria 427
CH - Svizzera 377
IN - India 362
FR - Francia 360
MX - Messico 207
AR - Argentina 188
BD - Bangladesh 188
JP - Giappone 171
NL - Olanda 159
NG - Nigeria 138
IQ - Iraq 129
PE - Perù 120
EC - Ecuador 119
ES - Italia 113
BE - Belgio 95
CI - Costa d'Avorio 89
ZA - Sudafrica 85
AU - Australia 83
CO - Colombia 78
ID - Indonesia 72
VE - Venezuela 72
SA - Arabia Saudita 68
PK - Pakistan 61
SN - Senegal 61
MA - Marocco 57
UZ - Uzbekistan 56
KE - Kenya 51
IL - Israele 48
CL - Cile 46
CZ - Repubblica Ceca 44
TW - Taiwan 38
UY - Uruguay 38
EG - Egitto 36
IE - Irlanda 35
PY - Paraguay 35
AE - Emirati Arabi Uniti 32
AL - Albania 29
DK - Danimarca 29
JM - Giamaica 28
PH - Filippine 28
IR - Iran 27
GR - Grecia 25
NZ - Nuova Zelanda 25
TN - Tunisia 22
JO - Giordania 21
PA - Panama 21
KZ - Kazakistan 20
MY - Malesia 20
AZ - Azerbaigian 19
NP - Nepal 19
BJ - Benin 18
OM - Oman 17
DZ - Algeria 16
RO - Romania 16
TT - Trinidad e Tobago 16
BO - Bolivia 14
PT - Portogallo 14
ET - Etiopia 13
LB - Libano 13
TH - Thailandia 13
EU - Europa 12
BB - Barbados 11
CR - Costa Rica 11
HR - Croazia 10
RS - Serbia 10
KG - Kirghizistan 9
NO - Norvegia 9
PS - Palestinian Territory 9
QA - Qatar 9
GE - Georgia 8
GT - Guatemala 8
LT - Lituania 8
SV - El Salvador 8
BH - Bahrain 7
MK - Macedonia 7
DO - Repubblica Dominicana 6
GY - Guiana 6
HU - Ungheria 6
MD - Moldavia 6
NI - Nicaragua 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
Totale 92.661
Città #
Montreal 4.620
Woodbridge 4.430
Ashburn 4.012
Hong Kong 3.983
Singapore 3.400
Ann Arbor 3.127
Houston 2.951
Fairfield 2.885
Chandler 2.247
Santa Clara 2.086
Dallas 2.067
Milan 1.624
Sofia 1.581
Shanghai 1.327
Beijing 1.222
Seattle 1.150
Jacksonville 1.147
Wilmington 1.059
Serra 1.056
New York 992
Cambridge 915
Ottawa 821
Hefei 788
Boardman 766
Seoul 701
Princeton 678
San Jose 673
Lawrence 614
Los Angeles 535
Nanjing 524
Medford 510
Izmir 487
Des Moines 404
Rome 376
Bern 342
Vienna 324
Munich 303
Istanbul 279
Florence 272
Pisa 255
Nanchang 234
Buffalo 222
Dearborn 221
London 220
Redwood City 216
Redondo Beach 215
Dong Ket 208
São Paulo 206
Jüchen 190
Ho Chi Minh City 186
Lancaster 176
San Diego 174
Boulder 161
Lucca 139
The Dalles 138
Lagos 136
Columbus 133
Tokyo 127
Frankfurt am Main 121
Bremen 120
Chicago 118
Council Bluffs 116
Rio de Janeiro 115
Falls Church 106
Hanoi 105
Kunming 105
Turku 103
Naples 100
Hebei 97
Changsha 94
Helsinki 90
Abidjan 89
Norwalk 88
Shenyang 83
Brussels 82
Ogden 81
Düsseldorf 80
Tianjin 78
Lima 77
Warsaw 77
Belo Horizonte 76
Guangzhou 69
Baghdad 59
Dakar 58
Phoenix 58
Washington 58
Jiaxing 57
Hangzhou 56
Pune 55
Palermo 54
Bari 53
Nuremberg 53
Nürnberg 53
Fuzhou 52
Tashkent 51
Toronto 51
Brasília 45
Grafing 45
Marseille 45
Dhaka 44
Totale 64.052
Nome #
L’inibizione transitoria o permanente della sintesi di noradrenalina peggiora la tossicità nigrostriatale in vari modelli di malattia di Parkinson 3.817
Parkinsonism by MPTP in mice: a model for regenerative processes of nigrostriatal dopaminergic pathway 3.450
Anatomia funzionale della formazione reticolare nel tronco encefalico dell'uomo 1.829
Barr: Il Sistema Nervoso dell'Uomo- Basi di Neuroanatomia 1.039
Anatomia Umana Normale. 1500 quiz a scelta multipla di Anatomia Umana Normale 727
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 604
Un nuovo modello sperimentale di epilessia limbica: la sensitizzazione con MDMA (ecstasy) produce modificazioni persistenti EEG e crisi epilettiche 471
Anatomia Dell'Uomo 334
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease 332
Chronic alcohol administration causes expression of calprotectin and RAGE altering the distribution of zinc ions in mouse testis 292
Neurons other than motor neurons in motor neuron disease 265
Psychopharmacology: drugs, the brain and behavior. 247
The chemical neuroanatomy of vagus nerve stimulation. 245
L’inibizione transitoria dell’enzima dopamina beta-idrossilasi estende ai neuroni noradrenergici i processi di neurodegenerazione 239
Pharmacological manipulation of embryonic dopaminergic neurons implanted in adult mouse striatum: a new therapeutical approach to Parkinson’s disease. 236
Combined light and electron microscopy (CLEM) to quantify methamphetamine-induced alpha-synuclein-related pathology 234
Embryonic neural grafts induce recovery in mice with permanent striatal lesion 220
The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation. 220
Protection by apomorphine in two independent models of acute inhibition of oxidative metabolism in rodents. 216
Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat 216
(+)MK-801 PREVENTS THE DDC-INDUCED ENHANCEMENT OF MPTP TOXICITY IN MICE 214
Clinical Trials for Neuroprotection in ALS 214
Anatomia funzionale del sistema nervoso periferico spinale dell'Uomo 212
In search for a gold-standard procedure to count motor neurons in the spinal cord 206
Dopamine stimulation via infusion in the lateral ventricle 205
Guidelines for the use and interpretation of assays for monitoring autophagy. 203
Locus coeruleus and neuronal plasticity in a model of focal limbic epilepsy 202
Continuous subcutaneous infusion of aporphine rescues nigrostriatal dopaminergic terminals following MPTP injection in mice 201
Pharmacological modulation of regenerative processes aftar nigrostriatal dopaminergic lesion: a new therapeutical approach to Parkinson’s disease 200
Fine ultrastructure and biochemistry of PC12 cells: A comparative approach to understand neurotoxicity 199
Loud noise exposure produces DNA, neurotransmitter, and immunohistochemical alterations within specific brain areas 198
Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. 197
Next Generation Sequencing and ALS: known genes, different phenotyphes 195
Autophagy and mitochondriogenesis 194
Realdo Colombo in the fifth centenary of his birth. 194
Analysis of Single, Purified Inclusions as a Novel Approach to Understand Methamphetamine Neurotoxicity 193
Protective effects of long-term lithium administration in a slowly progressive SMA mouse model 192
Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. 190
The emerging picture of ALS: a multisystem, not only a “motor neuron disease” 190
DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy) 189
The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders 189
Region-specific DNA alterations in focally induced seizures 189
Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death 188
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. 188
MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss 187
The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations 187
Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cells 186
Compartment-dependent mitochondrial alterations in experimental als, the effects of mitophagy and mitochondriogenesis 185
Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice 183
Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG) 183
Time-dependent changes in adrenal cortex ultrastructure and corticosterone levels after noise exposure in male rats 183
Characterization of motor neuron loss in animal models featuring prolonged disease duration 182
Clonidine prevents while yohimbine enhances MPTP toxicity in mice. 181
MDMA and seizures: a dangerous liaison? 181
The Neuroanatomy of the Reticular Nucleus Locus Coeruleus in Alzheimer's Disease. 181
Egas Moniz: 90 Years (1927-2017) from Cerebral Angiography. 181
The pleiotropic functionality of endogenous 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogs: a powerful tool to target interlinked diseases such as obesity and neurodegeneration 180
Actions of the tremorgenic mycotoxin verruculogen on catecholamine release in the central nervous system 179
3-(Fur-2-yl)-10-(2-Phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a Novel Adenosine Receptor Antagonist with (2A)-Mediated Neuroprotective EffeCTS 179
Autophagy promotes survival of dopaminergic neurons 177
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. 177
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection 176
Novel Therapeutic Target in PD: Experimental Models. 175
From dopamine metabolism to Parkinson’s disease. 175
Noradrenaline in Parkinson's disease: from disease progression to current therapeutics 175
Strategies for clinical approach to neurodegeneration in Amyotrophic lateral sclerosis. 175
AMPA receptor desensitization as a determinant of vulnerability to focally evoked status epilepticus 174
Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment 174
Effects of Pretreatment with N-(2-Chloroethyl)-N- Ethyl-2-Bromobenzylamine (DSP-4) of Methamphetamine Pharmacokinetics and Striatal Dopamine losses 174
DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations 174
Effect of metadoxine on striatal dopamine levels in C57 black mice 173
Pharmacological modulation of regenerative processes after nigrostriatal dopaminergic lesion: A new therapeutical approach to Parkinson's disease 173
Intrastriatal injection of D1 or D2 dopamine agonists affects glucose utilization in both the direct and indirect pathways of the rat basal ganglia 172
Ultrastructural characterization at scanning and transmission electron microscope in PC12 cells following different neurotoxins 172
In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration 172
Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity 171
Does autophagy worsen or improve the survival of dopaminergic neurons? 171
Lithium does protect in amyotrophic lateral sclerosis: results on human patients and mechanism involved in transgenic mice. 170
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 170
Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in Amyotrophic Lateral Sclerosis 170
Induction of the wnt inhibitor, dickkopf-1, is associated with neurodegeneration related to temporal lobe epilepsy 170
Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. 169
A novel approach to understand neurodegeneration: an analysis of single, purified inclusions 169
The neuroanatomical features of the locus coeruleus in neurodegeneration 169
The autophagy status of cancer stem cells in gliobastoma multiforme: From cancer promotion to therapeutic strategies 169
AR for Shoulder Rehabilitation with Microsoft HoloLens 169
PHARMACOLOGICAL MANIPULATION OF EMBRYONIC DOPAMINERGIC-NEURONS IMPLANTED IN ADULT-MOUSE STRIATUM - A NEW THERAPEUTIC APPROACH TO PARKINSONS-DISEASE 168
Focal intracerebral elevation of L-lactate is anticonvulsant. 168
A damage to locus coeruleus neurons converts sporadic seizures into self-sustaining limbic status epilepticus 168
Ambiguous Effects of Autophagy Activation Following Hypoperfusion/Ischemia 168
The role of nitric oxide in focally-evoked limbic seizures 167
Activation of brain metabolism and fos during limbic seizures: The role of Locus Coeruleus 167
MDMA (ecstasy) neurotoxicity extends beyond the basal ganglia 166
CAPS1 regulates catecholamine loading of large dense-core vesicles 166
The effects of proteasome on baseline and methamphetamine-dependent dopamine transmission 166
Cell clearing systems bridging neuro-immunity and synaptic plasticity 166
Endogenous 3-iodothyronamine (T1Am) and synthetic thyronamine-like analog SG-2 act as novel pleiotropic neuroprotective agents through the modulation of SIRT6 166
Naltrexone-induced panic attacks. 165
Intracellular pathways underlying the effects of lithium 165
Lack of α1b-adrenergic receptor protects against epileptic seizures 165
Totale 29.699
Categoria #
all - tutte 240.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 240.441


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.218 0 0 0 0 0 0 405 406 810 366 383 848
2021/20226.758 263 522 161 366 1.211 995 250 319 283 205 379 1.804
2022/20237.471 907 767 468 740 1.023 1.098 180 540 1.098 90 438 122
2023/202414.129 948 792 814 452 1.135 1.132 284 239 137 7.150 226 820
2024/202520.426 173 800 228 1.121 1.757 2.005 1.777 1.176 2.125 2.638 2.172 4.454
2025/202613.305 1.234 2.894 2.597 1.930 1.813 2.027 810 0 0 0 0 0
Totale 94.457